![(1R,5S)-1,2,3,4,5,6-HEXAHYDRO-8H-1,5-METHANOPYRIDO[1,2-A][1,5]DIAZOCIN-8-ONE in PDB entry 5syo, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/5syo_entity_2_side_image-200x200.png "Homo pentameric assembly 1 of PDB entry <span class='highlight'>5syo</span> contains 2 copies of <span class='highlight'>(1R,5S)-1,2,3,4,5,6-HEXAHYDRO-8H-1,5-METHANOPYRIDO[1,2-A][1,5]DIAZOCIN-8-ONE</span>. Side view.")
![(1R,5S)-1,2,3,4,5,6-HEXAHYDRO-8H-1,5-METHANOPYRIDO[1,2-A][1,5]DIAZOCIN-8-ONE in PDB entry 5syo, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/5syo_entity_2_top_image-200x200.png "Homo pentameric assembly 1 of PDB entry <span class='highlight'>5syo</span> contains 2 copies of <span class='highlight'>(1R,5S)-1,2,3,4,5,6-HEXAHYDRO-8H-1,5-METHANOPYRIDO[1,2-A][1,5]DIAZOCIN-8-ONE</span>. Top view.")
Environment details NEW
C5E 301 bound to chain C
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.